Controlling Escherichia coli O157: The emerging challenge

Journal of Hospital Infection

Volumn 43, Issue SUPPL. 1, 1999, Pages

  Coia, J E ^a  

^a NHS LOTHIAN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; ENTEROBACTER INFECTION; EPIDEMIC; ESCHERICHIA COLI O157; EUROPE; FOOD SAFETY; HEALTH PROMOTION; HONG KONG; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; PREVALENCE; SEASONAL VARIATION;

DIARRHEA; ESCHERICHIA COLI INFECTIONS; HUMANS; OCCUPATIONAL DISEASES;

EID: 22644440059     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(99)90084-1     Document Type: Article

References (26)

1. Coia JE. Clinical, microbiological and epidemiological aspects of Escherichia coli O157 infection. FEMS Immunol Med Microb 1998; 20: 1-9.
2. Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli and the associated hemolytic uremic syndrome. Epidemiol Rev 1991; 13: 60-97.
3. Prevention and control of enterohaemorrhagic Escherichia coli (EHEC) infections: Report of a WHO consultation. Geneva: WHO, 1997.
4. Coia JE, Sharp JCM, Campbell DM, Curnow J, Ramsay CN. Environmental risk factors for sporadic E. coli O157 infection in Scotland: Results of a descriptive epidemiology study. J Infect 1998; 36: 317-321.
5. Willshaw GA, Thirwell J, Jones AP, Parry S, Salmon RL, Hickey M. Verocytotoxin-producing Escherichia coli O157 in beefburgers linked to an outbreak of diarrhoea, haemorrhagic colitis and haemolytic uraemic syndrome in Britain. Lett Appl Microb 1994; 19: 304-307.
6. Boyse J, Thomson-Carter F, Carter P, Booth IR. Acid tolerance in VTEC. Supplement to SCIEH Weekly Report 1997; 97/13: 19-20.
7. Maule A. The survival of verocytotoxigenic Escherichia coli on surfaces and the effect of disinfection. PHLS 22nd Annual Scientific Conference. Warwick, 1997.
8. Upton PA, Coia JE. Outbreak of Escherichia coli O157 associated with pasteurised milk supply. Lancet 1994; 344: 1015.
9. Report on the circumstances leading to the 1996 outbreak of infection with E. coli O157 in central Scotland, the implications for food safety and the lessons to be learned. Edinburgh: The Stationery Office, 1997.
10. Hancock DD, Besser TE, Rice DH, Herriott DE, Tarr PI. A longitudinal study of Escherichia coli O157 in fourteen cattle herds. Epidemiol Infect 1997; 118: 193-195.
11. Coia JE. Nosocomial and laboratory-acquired infection with Escherichia coli O157. J Hosp Infect 1998; 40: 107-113.
12. Carter AO, Borczyk AA, Carlson JAK et al. A severe outbreak of Escherichia coli O157:H7-associated hemorrhagic colitis in a nursing home. N Engl J Med 1987; 317: 1496-1500.
13. Belongia EA, Osterholm MT, Soler JT, Ammend DA, Braun JE, MacDonald KL. Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities. J Am Med Assoc 1993; 269: 883-888.
14. Pavia AT, Nichols CR, Green DP et al. Hemolytic-uraemic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: Clinical and epidemiological observations. J Pediat 1990; 116: 544-551.
15. Kohli HS, Chaudhuri AKR, Todd WTA, Mitchell AAB, Liddell KG. A severe outbreak of E. coli O157 in two psychogeriatric wards. J Pub Health Med 1994; 16: 11-15.
16. Sharp JCM, Reilly WJ, Coia JE, Curnow J, Synge BA. Escherichia coli O157 in Scotland: an epidemiological overview 1984-1994. PHLS Microb Digest 1995; 12: 134-140.
17. Karmali MA, Arbus GS, Petric M et al. Hospital-acquired Escherichia coli O157:H7 associated haemolytic uraemic syndrome in a nurse. Lancet 1988; 1: 526.
18. Weightman NC, Kirby PJG. Nosocomial Escherichia coli O157 infection. In Abstracts of the 4th International Conference of the Hospital Infection Society. J Hosp Infect 1998; 40: Supplement A.
19. Preston M, Broczyk A, Davidson R et al. Hospital outbreak of Escherichia coli O157:H7 associated with a rare phage type. Canada Communicable Disease Report 1997; 23: 33-36.
20. Consultants in Public Health Medicine (Communicable Diseases and Environmental Health) Working Group in Scotland. Guidelines on bacteriological clearance following gastro-intestinal infection. SCIEH Weekly Report 1996; 30 (96/ 01): 6-8.
21. Kavi J, Roworth M, Nathwani D, Craig K. The successful use of ciprofloxacin to terminate an outbreak of Eschenchia coli O157 infection. In Abstracts of the 4th International Conference of the Hospital Infection Society, J Hosp Infect 1998; 40: Supplement A.
22. Ostroff SM, Kobayashi JM, Lewis JH. Infections with Escherichia coli O157:H7 in Washington State: The first year of statewide disease surveillance. J Am Med Assoc 1989; 262: 355-359.
23. Booth L, Rowe B. Possible occupational acquisition of Escherichia coli O157 infection. Lancet 1993; 342: 1298-1299.
24. Burnens AP, Zbinden R, Kaempf L, Heinzer I, Nicolet J. A case of laboratory acquired infection with Escherichia coli O157:H7. Zentralblatt für Bakteriologie 1993; 279: 512-517.
25. Rao GG, Saunders BP, Masterton RG. Laboratory acquired verotoxin producing Escherichia coli (VTEC) infection. J Hosp Infect 1996; 33: 228-230.
26. Anonymous. Escherichia coli O157 infection acquired in the laboratory. CDR Weekly Report 1996; 6: 239.